Cancer Therapy Current Events | Cancer Therapy News | 4
|
| Page
4 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for... view more... (2008-07-10)
PSA doubling predicts prostate cancer recurrence
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for... view more... (2007-04-10)
Whites take supplemental breast cancer therapy more often than blacks
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women. view more (2007-10-08)
Identifying the potential for tamoxifen resistance in patients
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. view more (2009-06-11)
Many oncologists unaware of cancer clot risk
Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognise their clotting effects and preventive measures are rarely used, finds a study in this week’s BMJ. view more (2003-09-10)
Molecular studies in cancer of the colon
According to Dr. Jesús García-Foncillas, Director of the Department of Oncology at the University Hospital (University of Navarra), molecular studies in cancer of the colon will contribute to the establishment of more efficient and less toxic treatments. view more (2005-10-24)
PET scan can non invasively measure early assessment of treatment for common type of breast cancer
Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual... view more... (2009-05-27)
Gene therapy may protect normal tissues during radiation retreatment for lung cancer
Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer. view more (2005-10-17)
Hormone therapy associated with reduced colorectal cancer risk
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer... view more... (2009-01-08)
Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemia
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome. view more (2009-07-07)
Largest PSA bounce study eases worry of prostate cancer returning
Prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy-called a PSA bounce-are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise. view more (2006-11-09)
Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer. view more (2008-02-07)
Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. view more (2009-11-03)
Chemotherapy gel may fight breast cancer and reduce breast deformity
Women who undergo surgery for breast cancer followed by radiation therapy often experience breast deformities that can only be corrected through reconstructive surgery. view more (2006-04-25)
Common osteoporosis treatment may help men with prostate cancer suffering from bone loss
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis. view more (2006-02-27)
Combining liver cancer treatments doubles survival rates, UVA researchers find
By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct. view more (2008-04-16)
Prostate cancer therapy increases risk of fractures and cardiovascular-related death
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis. view more (2009-04-27)
Standard treatment for prostate cancer may encourage spread of disease
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. view more (2007-10-01)
Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
Mayo Clinic today reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin. view more (2007-10-24)
Researchers study effects of Aricept in pediatric brain cancer survivors
A pediatric oncologist at Brenner Children's Hospital is evaluating whether a drug typically used to treat Alzheimer's patients will help brain cancer survivors avoid the learning and memory problems that are common after radiation therapy. view more (2006-11-06)
|
|
| Page
4 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
|
